Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
NDTV
Known as a "pharmacy of the world", India supplies 45% of all generic medicines to Africa.
Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
Known as a "pharmacy of the world", India supplies 45% of all generic medicines to Africa.
The deaths of 69 children in Gambia - one of the worst such incidents involving drugs from India - have come as a blow to the industry whose exports more than doubled in the last decade to hit $24.5 billion last fiscal year.
Indian authorities inspected Maiden's main factory in the state of Haryana four times this month and said they suspended all its manufacturing activities on Tuesday after finding that the firm had been manufacturing and testing drugs in violation of rules "across its manufacturing and testing activities".